M B Chinappa, CFO, Syngene International LTD, Peter Bains, Director& CEO, Syngene International LTD, Kiran Muzumdar Shaw, MD, Syngene International LTD & Manoj Nerurkar, COO, Syngene International LTD during the press conference to announce Initial Public offer in Mumbai on Thursday, 16 July 2015. Pharmaceutical company Biocon Ltd has fixed a price band for an initial public offering (IPO) of its subsidiary Syngene International Ltd at Rs.240-250 per equity share.
Tags: Chief Financial Officer at Syngene International LimitedDirector and Chief Executive Officer at Syngene International LimitedDirector at Syngene International LimitedChief Operating Officer at Syngene International Limitedhorizontal
Credit balance: 0